Quick Answer
ADMA BIOLOGICS, INC. reported Net Income of $146.93 million for fiscal year 2025.
ADMA BIOLOGICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $146.93M | -25.7% |
| 2024 | $197.67M | +800.0% |
| 2023 | -$28.24M | +57.2% |
| 2022 | -$65.90M | +8.0% |
| 2021 | -$71.65M | +5.4% |
| 2020 | -$75.75M | -56.9% |
| 2019 | -$48.28M | +26.6% |
| 2018 | -$65.74M | -50.2% |
| 2017 | -$43.76M | -124.2% |
| 2016 | -$19.52M | -8.6% |
| 2015 | -$17.97M | -6.9% |
| 2014 | -$16.81M | -8.3% |
| 2013 | -$15.53M | -112.7% |
| 2012 | -$7.30M | -23.7% |
| 2011 | -$5.90M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.43M | +1.4% | +6.5% |
| June 30, 2025 | $34.22M | +6.7% | +27.2% |
| March 31, 2025 | $26.90M | +51.1% | -25.1% |
| September 30, 2024 | $35.91M | +1300.0% | +12.0% |
| June 30, 2024 | $32.06M | +603.2% | +80.1% |
| March 31, 2024 | $17.81M | +362.3% | +594.2% |
| September 30, 2023 | $2.56M | +117.2% | +140.3% |
| June 30, 2023 | -$6.37M | +53.7% | +6.2% |
- ADMA BIOLOGICS, INC. showed a decrease of -25.7% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, ADMA BIOLOGICS, INC.’s net income has grown by 2588.9% (from -$5.90 million to $146.93 million).
- The most recent figure is from ADMA BIOLOGICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: